Corbus Pharmaceuticals Holding

Stock Chart, Company Information, and Scan Results

$7.54(as of Jun 2, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Corbus Pharmaceuticals Holding Company Information, Fundamentals, and Technical Indicators

Stock Price$7.54
Ticker SymbolCRBP
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees36
CountyUSA
Market Cap$143.6M

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

Corbus Pharmaceuticals Holding In Our Stock Scanner

As of Jun 03, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Bull FlagScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.